Reports Q2 revenue $70.801M, consensus $64.07M. “This divestiture is transformational for both the Blade Passenger business and Blade’s Medical division, that will remain a standalone publicly traded company. We strongly believe that this is the best path forward to create long term value for all stakeholders including employees, customers, partners and shareholders,” said Rob Wiesenthal, Blade’s Chief Executive Officer. “Blade’s Medical business has grown from 12% of revenue in 2020 to over 60% of revenue over the last year.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLDE:
- Cathie Wood’s Manic Monday Moves: Buys AMD and Nvidia, Sells Roblox and Blade Air Mobility
- M&A News: Joby Aviation Stock Soars as Blade Deal Fast-Tracks Air Taxi Rollout
- Tesla grants Musk big payout, Wayfair reports Q2 beat: Morning Buzz
- Morning Movers: Wayfair surges following second quarter results
- Blade Air Mobility Sells Passenger Division to Joby